Regulation of caspase-9 activity by differential binding to the apoptosome complex

Pothana Saikumar, Margarita Mikhailova, Srilakshmi Pandeswara

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Proteolytic processing of procaspase-9 is required for its activation, but processing in itself appears to be insufficient for its activity. We studied caspase activation in a cell-free system and found that incubation of cytosol from rat kidney proximal tubule cells with Cytochrome c (Cyt c) and dATP results in rapid autocatalytic processing of procaspase-9 from ∼50 kD to ∼38 kD size fragment. Moreover, Cyt c concentration influences the production of alternatively processed forms of caspase-9. At lower Cyt c concentration (0.01-0.05 mg/ml), two fragments of caspase-9 of the size 38 and 40 kD are produced. In contrast, at higher concentrations of Cyt c (>0.1 mg/ml) only 38 kD fragment will prevail. However, our failure to capture processed caspase-9 by affinity labeling or coelution with Apaf-1 suggested that caspase-9 undergoes a conformational change during its enzymatic action on effector caspases, resulting in its release from the apoptosome complex and inactivation. In support of this hypothesis, catalytic inhibitors of caspase-9 prevented its release from the apoptosome complex without affecting its auto-processing and allowed successful capture of active caspase-9 (38 kD) and its complex by affinity labeling. These observations suggest that complex allosteric interactions with the apoptosome complex influence caspase-9 activity and function by controlling not only the induction of its enzymatic activity, but also its rapid termination.

Original languageEnglish (US)
Pages (from-to)3343-3354
Number of pages12
JournalFrontiers in Bioscience
Volume12
Issue number9
DOIs
StatePublished - May 1 2007

Fingerprint

Apoptosomes
Caspase 9
Cytochromes c
Processing
Labeling
Chemical activation
Effector Caspases
Proximal Kidney Tubule
Cell-Free System
Caspases
Cytosol
Rats

Keywords

  • Apaf-1
  • Apoptosis
  • Apoptosome
  • Caspase-3
  • Caspase-9
  • Cytochrome c
  • Inhibitor
  • Research article

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Regulation of caspase-9 activity by differential binding to the apoptosome complex. / Saikumar, Pothana; Mikhailova, Margarita; Pandeswara, Srilakshmi.

In: Frontiers in Bioscience, Vol. 12, No. 9, 01.05.2007, p. 3343-3354.

Research output: Contribution to journalArticle

Saikumar, Pothana ; Mikhailova, Margarita ; Pandeswara, Srilakshmi. / Regulation of caspase-9 activity by differential binding to the apoptosome complex. In: Frontiers in Bioscience. 2007 ; Vol. 12, No. 9. pp. 3343-3354.
@article{f7abb568db0a42bbb3b3170dc5dded33,
title = "Regulation of caspase-9 activity by differential binding to the apoptosome complex",
abstract = "Proteolytic processing of procaspase-9 is required for its activation, but processing in itself appears to be insufficient for its activity. We studied caspase activation in a cell-free system and found that incubation of cytosol from rat kidney proximal tubule cells with Cytochrome c (Cyt c) and dATP results in rapid autocatalytic processing of procaspase-9 from ∼50 kD to ∼38 kD size fragment. Moreover, Cyt c concentration influences the production of alternatively processed forms of caspase-9. At lower Cyt c concentration (0.01-0.05 mg/ml), two fragments of caspase-9 of the size 38 and 40 kD are produced. In contrast, at higher concentrations of Cyt c (>0.1 mg/ml) only 38 kD fragment will prevail. However, our failure to capture processed caspase-9 by affinity labeling or coelution with Apaf-1 suggested that caspase-9 undergoes a conformational change during its enzymatic action on effector caspases, resulting in its release from the apoptosome complex and inactivation. In support of this hypothesis, catalytic inhibitors of caspase-9 prevented its release from the apoptosome complex without affecting its auto-processing and allowed successful capture of active caspase-9 (38 kD) and its complex by affinity labeling. These observations suggest that complex allosteric interactions with the apoptosome complex influence caspase-9 activity and function by controlling not only the induction of its enzymatic activity, but also its rapid termination.",
keywords = "Apaf-1, Apoptosis, Apoptosome, Caspase-3, Caspase-9, Cytochrome c, Inhibitor, Research article",
author = "Pothana Saikumar and Margarita Mikhailova and Srilakshmi Pandeswara",
year = "2007",
month = "5",
day = "1",
doi = "10.2741/2317",
language = "English (US)",
volume = "12",
pages = "3343--3354",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "9",

}

TY - JOUR

T1 - Regulation of caspase-9 activity by differential binding to the apoptosome complex

AU - Saikumar, Pothana

AU - Mikhailova, Margarita

AU - Pandeswara, Srilakshmi

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Proteolytic processing of procaspase-9 is required for its activation, but processing in itself appears to be insufficient for its activity. We studied caspase activation in a cell-free system and found that incubation of cytosol from rat kidney proximal tubule cells with Cytochrome c (Cyt c) and dATP results in rapid autocatalytic processing of procaspase-9 from ∼50 kD to ∼38 kD size fragment. Moreover, Cyt c concentration influences the production of alternatively processed forms of caspase-9. At lower Cyt c concentration (0.01-0.05 mg/ml), two fragments of caspase-9 of the size 38 and 40 kD are produced. In contrast, at higher concentrations of Cyt c (>0.1 mg/ml) only 38 kD fragment will prevail. However, our failure to capture processed caspase-9 by affinity labeling or coelution with Apaf-1 suggested that caspase-9 undergoes a conformational change during its enzymatic action on effector caspases, resulting in its release from the apoptosome complex and inactivation. In support of this hypothesis, catalytic inhibitors of caspase-9 prevented its release from the apoptosome complex without affecting its auto-processing and allowed successful capture of active caspase-9 (38 kD) and its complex by affinity labeling. These observations suggest that complex allosteric interactions with the apoptosome complex influence caspase-9 activity and function by controlling not only the induction of its enzymatic activity, but also its rapid termination.

AB - Proteolytic processing of procaspase-9 is required for its activation, but processing in itself appears to be insufficient for its activity. We studied caspase activation in a cell-free system and found that incubation of cytosol from rat kidney proximal tubule cells with Cytochrome c (Cyt c) and dATP results in rapid autocatalytic processing of procaspase-9 from ∼50 kD to ∼38 kD size fragment. Moreover, Cyt c concentration influences the production of alternatively processed forms of caspase-9. At lower Cyt c concentration (0.01-0.05 mg/ml), two fragments of caspase-9 of the size 38 and 40 kD are produced. In contrast, at higher concentrations of Cyt c (>0.1 mg/ml) only 38 kD fragment will prevail. However, our failure to capture processed caspase-9 by affinity labeling or coelution with Apaf-1 suggested that caspase-9 undergoes a conformational change during its enzymatic action on effector caspases, resulting in its release from the apoptosome complex and inactivation. In support of this hypothesis, catalytic inhibitors of caspase-9 prevented its release from the apoptosome complex without affecting its auto-processing and allowed successful capture of active caspase-9 (38 kD) and its complex by affinity labeling. These observations suggest that complex allosteric interactions with the apoptosome complex influence caspase-9 activity and function by controlling not only the induction of its enzymatic activity, but also its rapid termination.

KW - Apaf-1

KW - Apoptosis

KW - Apoptosome

KW - Caspase-3

KW - Caspase-9

KW - Cytochrome c

KW - Inhibitor

KW - Research article

UR - http://www.scopus.com/inward/record.url?scp=34347272654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347272654&partnerID=8YFLogxK

U2 - 10.2741/2317

DO - 10.2741/2317

M3 - Article

C2 - 17485304

AN - SCOPUS:34347272654

VL - 12

SP - 3343

EP - 3354

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 9

ER -